Abstract
Introduction: Central neurocytomas are rare primary central nervous system tumors. The main treatment method is gross total surgical resection that can only be performed in half of the patients. As the possibility of relapse is higher, post-resection treatment of the remaining tu
Highlights
Central neurocytomas are rare primary central nervous system tumors
Case Report: We present a 29-year-old patient with atypical central neurocytomas whose residual tumors were well controlled by CyberKnife Robotic Surgery or Radiosurgery (CKRS)
Central neurocytoma is termed as a grade II benign brain tumor by World Health Organization (WHO)
Summary
Known to be excessively radiosensitive, stereotactic radiosurgery is a more preferred option due to its lower toxicity as an alternative treatment modality. CyberKnife robotic surgery, the latest radiosurgical method, has never been used in cases of central neurocytoma. Affiliations: 1Associate Professor, Department of Radiation Oncology, Faculty of Medicine, Recep Tayyip Erdogan University, Rize, Turkey; 2Associate Professor, Department of Neurosurgery, Health of Sciences University, Samsun Training and Research Hospital, Samsun, Turkey; 3Associate Professor, Department of Pathology, Faculty of Medicine, Recep Tayyip Erdogan University, Rize, Turkey; 4Consultant, Department of Radiation Oncology, Health of Sciences University, Samsun Training and Research Hospital, Samsun, Turkey. Corresponding Author: Sema Yilmaz Rakici, Associate Professor, Department of Radiation Oncology, Faculty of Medicine, Recep Tayyip Erdogan University, İslampasa mah, Sehitlik sok., 53100, Rize, Turkey; Email: sema.rakici@ erdogan.edu.tr. Well controlled atypical central neurocytoma by CyberKnife radiosurgery: Review of the literature with a case report.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
